European Stakeholders Appeal EPO Ruling to Uphold Gilead’s Sofosbuvir Patent AJMC.com Managed Markets Network
Recently, 6 European organizations appealed a European Patent Office (EPO) decision to uphold Gilead Science’s patent on the hepatitis C drug sofosbuvir, …